Antitumor and antiangiogenic effect of the dual EGFR and HER-2 tyrosine kinase inhibitor lapatinib in a lung cancer model

  1. Diaz, R.
  2. Nguewa, P.A.
  3. Parrondo, R.
  4. Perez-Stable, C.
  5. Manrique, I.
  6. Redrado, M.
  7. Catena, R.
  8. Collantes, M.
  9. Peñuelas, I.
  10. Díaz-González, J.A.
  11. Calvo, A.
Journal:
BMC Cancer

ISSN: 1471-2407

Year of publication: 2010

Volume: 10

Type: Article

DOI: 10.1186/1471-2407-10-188 GOOGLE SCHOLAR lock_openOpen access editor